|
|
||||||||


Departments of
*
Microbiology and
Medicine, Boston University School of Medicine, Boston, MA 02118;
Department of Microbiology and Immunology, Temple University School of Medicine, Philadelphia, PA 19140; and
§
Departments of Laboratory Medicine and Immunobiology, Yale University School of Medicine, New Haven, CT 06520
The fate of an autoreactive B cell is determined in part by the nature of the interaction of the B cell receptor with its autoantigen. In the lpr model of systemic autoimmunity, as well as in certain human diseases, autoreactive B cells expressing rheumatoid factor (RF) binding activity are prominent. A murine B cell transgenic model in which the B cell receptor is a RF that recognizes IgG2a of the j allotype (IgG2aj), but not the b allotype, was used in this study to investigate how the form of the autoantigen influences its ability to activate B cells. We found that sera from autoimmune mice, but not from nonautoimmune mice, were able to induce the proliferation of these RF+ B cells but did not stimulate B cells from RF- littermate controls. The stimulatory factor in serum was found to be IgG2aj, but the IgG2aj was stimulatory only when in the form of immune complexes. Monomeric IgG2aj failed to stimulate. Immune complexes containing lupus-associated nuclear and cytoplasmic autoantigens were particularly potent B cell activators in this system. Appropriate manipulation of such autoantibody/autoantigen complexes may eventually provide a means for therapeutic intervention in patients with certain systemic autoimmune disorders.
This article has been cited by other articles:
![]() |
B. C. Beaudette-Zlatanova, T. Ling, M. J. Shlomchik, A. Marshak-Rothstein, and I. R. Rifkin B Cells and Dendritic Cells from V{kappa}8 Light Chain Transgenic Mice Activate MRL-lpr/gld CD4+ T Cells J. Immunol., July 1, 2006; 177(1): 45 - 52. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. Fields, M. H. Metzgar, B. D. Hondowicz, S.-A. Kang, S. T. Alexander, K. D. Hazard, A. C. Hsu, Y.-Z. Du, E. L. Prak, M. Monestier, et al. Exogenous and Endogenous TLR Ligands Activate Anti-Chromatin and Polyreactive B Cells. J. Immunol., June 1, 2006; 176(11): 6491 - 6502. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. M. R. Westwood, P. N. Nelson, and F. C. Hay Rheumatoid factors: what's new? Rheumatology, April 1, 2006; 45(4): 379 - 385. [Full Text] [PDF] |
||||
![]() |
J. William, C. Euler, E. Leadbetter, A. Marshak-Rothstein, and M. J. Shlomchik Visualizing the Onset and Evolution of an Autoantibody Response in Systemic Autoimmunity J. Immunol., June 1, 2005; 174(11): 6872 - 6878. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Doerre, K. P. Mesires, K. M. Daley, T. McCarty, S. Knoetig, and R. B. Corley Reductions in I{kappa}B{epsilon} and Changes in NF-{kappa}B Activity during B Lymphocyte Differentiation J. Immunol., January 15, 2005; 174(2): 983 - 991. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Latz, A. Visintin, T. Espevik, and D. T. Golenbock Mechanisms of TLR9 activation Innate Immunity, December 1, 2004; 10(6): 406 - 412. [Abstract] [PDF] |
||||
![]() |
A. R. Ferguson, M. E. Youd, and R. B. Corley Marginal zone B cells transport and deposit IgM-containing immune complexes onto follicular dendritic cells Int. Immunol., October 1, 2004; 16(10): 1411 - 1422. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Marshak-Rothstein, L. Busconi, C. M. Lau, A. S. Tabor, E. A. Leadbetter, S. Akira, A. M. Krieg, G. B. Lipford, G. A. Viglianti, and I. R. Rifkin Comparison of CpG s-ODNs, chromatin immune complexes, and dsDNA fragment immune complexes in the TLR9-dependent activation of rheumatoid factor B cells Innate Immunity, August 1, 2004; 10(4): 247 - 251. [Abstract] [PDF] |
||||
![]() |
M. P. Cancro and J. F. Kearney B Cell Positive Selection: Road Map to the Primary Repertoire? J. Immunol., July 1, 2004; 173(1): 15 - 19. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. W. Boule, C. Broughton, F. Mackay, S. Akira, A. Marshak-Rothstein, and I. R. Rifkin Toll-like Receptor 9-Dependent and -Independent Dendritic Cell Activation by Chromatin-Immunoglobulin G Complexes J. Exp. Med., June 21, 2004; 199(12): 1631 - 1640. [Abstract] [Full Text] [PDF] |
||||
![]() |
L E Schiffer, N Hussain, X Wang, W Huang, J Sinha, M Ramanujam, and A Davidson Lowering anti-dsDNA antibodies--what's new? Lupus, December 1, 2002; 11(12): 885 - 894. [Abstract] [PDF] |
||||
![]() |
C. H. Nielsen and R. G. Q. Leslie Complement's participation in acquired immunity J. Leukoc. Biol., August 1, 2002; 72(2): 249 - 261. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |